companydata.dkcompanydata.dk

LIVINGCELL ApS: Financial statements 2025

CVR: 27205607

Source: annual report 2025, Danish Business Authority

01/07/2024 – 30/06/2025

LIVINGCELL ApS (CVR 27205607) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -13,500 and a net result of DKK -6,542 compared with DKK -17,604 the year before. Equity in the 2025 report amounted to DKK 115,908. The solvency ratio was 78.4%.

Gross Profit
DKK -13,500
Profit/Loss
DKK -6,542
Equity
DKK 115,908
Total Assets
DKK 147,931
Employees
0

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2025--14 t.-7 t.116 t.0
2024--24 t.-18 t.122 t.-
2023-344 t.268 t.405 t.-
2022-326 t.251 t.387 t.-
2021-365 t.282 t.416 t.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is LIVINGCELL ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2025

LIVINGCELL ApS: The 2024 annual report is outJan 13, 2025

LIVINGCELL ApS has published its annual report for 2024. Gross profit came to DKK -24,191, and the net result was DKK -17,604.

About LIVINGCELL ApS

LIVINGCELL ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2003. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The management consists of Anders Bek-Pedersen. The board consists of Anders Bek-Pedersen (chair). The company is owned by BEK-PEDERSEN HOLDING ApS. The company has 0 employees (2004). In 2025, the company reported a gross profit of DKK -13,500 and a net result of DKK -6,542 compared with DKK -17,604 the year before. Equity in the 2025 report amounted to DKK 115,908.

Source: annual report 2025, Danish Business Authority